Bubble-enhanced
shock waves induce the transient opening of the
blood-brain barrier (BBB) providing unique advantages for targeted
drug delivery of brain tumor therapy, but little is known about the
molecular details of this process. Based on our BBB model including
28 000 lipids and 280 tight junction proteins and coarse-grained
dynamics simulations, we provided the molecular-level delivery mechanism
of three typical drugs for the first time, including the lipophilic
paclitaxel, hydrophilic gemcitabine, and siRNA encapsulated in liposome,
across the BBB. The results show that the BBB is more difficult to
be perforated by shock-induced jets than the human brain plasma membrane
(PM), requiring higher shock wave speeds. For the pores formed, the
BBB exhibits a greater ability to self-heal than PM. Hydrophobic paclitaxel
can cross the BBB and be successfully absorbed, but the amount is
only one-third of that of PM; however, the absorption of hydrophilic
gemcitabine was almost negligible. Liposome-loaded siRNAs only stayed
in the first layer of the BBB. The mechanism analysis shows that increasing
the bubble size can promote drug absorption while reducing the risk
of higher shock wave overpressure. An exponential function was proposed
to describe the relation between bubble and overpressure, which can
be extended to the experimental microbubble scale. The calculated
overpressure is consistent with the experimental result. These molecular-scale
details on shock-assisted BBB opening for targeted drug delivery would
guide and assist experimental attempts to promote the application
of this strategy in the clinical treatment of brain tumors.